Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the...

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Pyrazinamide (PZA) is a critical first-line drug for tuberculosis (TB) treatment.
• Mycobacterium tuberculosis (Mtb) susceptibility testing is essential for effective TB management.
• The BACTEC MGIT 960 (M960) system is widely used for PZA susceptibility testing in liquid medium at acidic pH.

Purpose of the Study:

• To review literature on false PZA resistance observed in the M960 assay.
• To identify factors contributing to inaccurate PZA susceptibility results.
• To evaluate proposed modifications for improving the M960 PZA assay.

Main Methods:

• Literature review of studies investigating PZA resistance in Mtb.
• Analysis of factors influencing PZA activity in vitro.
• Examination of proposed adjustments to the M960 assay protocol.

Main Results:

• High Mtb inoculum density is a primary cause of false PZA resistance.
• Increased inoculum can elevate medium pH, impairing PZA efficacy.
• Proposed solutions consistently involve reducing Mtb inoculum levels.

Conclusions:

• False PZA resistance in the M960 assay is a significant issue in TB diagnostics.
• Reducing Mtb inoculum density is a practical and effective strategy to improve assay accuracy.
• Implementing lower inoculum densities can enhance reliable PZA susceptibility testing for TB patients.